2025³â 08¿ù 05ÀÏ È­¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92459°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



Çö´ëÂ÷, 7¿ù 33¸¸4794´ë ÆÇ¸Å

±¹³» ÆÇ¸Å 0.4% Áõ°¡, ÇØ¿Ü ÆÇ¸Å 0.5% Áõ°¡
Çö´ëÀÚµ¿Â÷°¡ 2025³â 7¿ù ±¹³» 5¸¸6227´ë, ÇØ¿Ü 27¸¸8567´ë µî Àü ¼¼°è ½ÃÀå¿¡¼­ Àü³â µ¿¿ù ´ëºñ 0.5% Áõ°¡ÇÑ ÃÑ 33¸¸4794´ë¸¦ ÆÇ¸ÅÇß´Ù. Áö³­ÇØ °°Àº ±â°£°ú ºñ±³ÇØ ±¹³» ÆÇ¸Å´Â 0.4% Áõ°¡ÇßÀ¸¸ç, ÇØ¿Ü ÆÇ¸Å´Â 0.5% Áõ°¡ÇÑ °ÍÀ¸·Î Áý°èµÆ´Ù. ±¹³» ÆÇ¸Å Çö´ëÂ÷´Â 2025³â 7¿ù ±¹³» ½ÃÀå¿¡¼­ Àü³â µ¿¿ù ´ëºñ 0.4% Áõ°¡ÇÑ 5¸¸6227´ë¸¦ ÆÇ¸ÅÇß´Ù. ¼¼´ÜÀº ±×·£Àú 4408´ë, ½î³ªÅ¸ 3314´ë, ¾Æ¹Ý¶¼ 6145´ë µî ÃÑ 1¸¸4483´ë¸¦ ÆÈ¾Ò´Ù. RV´Â ÆÓ¸®¼¼À̵å 6238´ë, ½ÑŸÆä 4252´ë, Åõ½Ñ 4011´ë, ÄÚ³ª 2592´ë, ij½ºÆÛ 1245´ë µî ÃÑ 2¸¸3258´ë ÆÇ¸Å ...

¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
±×¸°Çǽº, ¾î¸°À̵é°ú ÃÊ´ëÇü ¹Ù´Ù º¸È£ ÆÛÁñ ¼³Ä¡ (2024-06-11)
Çö´ëÂ÷¡¤±â¾Æ, ¡®Àü±âÂ÷ ¾È½É Á¡°Ë ¼­ºñ½º¡¯ ½Ç½Ã (2024-08-14)
LG»ýȰ°Ç°­ ´ÙÀÌ¼Ò Àü¿ë ¡®CNP ¹ÙÀÌ ¿Àµð-Ƽµð ½ºÆÌ Ä«¹Ö Á©¡¯ (2024-12-01)
¡®¾Æºü´Â ²ÉÁ߳⡯ »çÀ¯¸®, ¡®45¼¼ ²É¾öºü¡¯·Î Àü°Ý ÇÕ·ù (2024-10-17)
IT ¾Æ¿ô ¼Ò½Ì, ÇØ¿Ü °³¹ßÀÚ ¼öÁØ ³ô¾ÆÁ® (2024-08-03)
Andersen Global Strengthens Presence in the Dominican Republ... (2025-01-04)
GS25, ¡®µþ±â»÷µåÀ§Ä¡¡¯ °úÀÏ MD¿Í Çù¾÷À¸·Î ǰÁú °­È­ (2024-12-05)
From Rice Farming to Biochar: Greenery to Present Innovative... (2024-11-20)
°æ¿µ´ëÇпø Á¹¾÷ÀÚ¿¡ ´ëÇÑ ½Å·Úµµ Áõ°¡¿Í ä¿ë È£Á¶ Àü¸Á (2024-07-08)
ÁÖÅÃÁ¶ÇÕ ¼º°ø °æÇèÀÚ°¡ ¾Ë·ÁÁÖ´Â ¡®ÁÖÅÃÁ¶ÇÕ ¼º°ø Çʵ¶¼­¡¯ (2024-05-28)
¡®2024 Ãæ³² À̽ºÆ÷Ã÷ JOB Äܼ­Æ®¡¯ °³ÃÖ (2024-10-25)
GS¸®Å×ÀÏ¡¤Ä«Ä«¿À¡¤¸ð¿§Çì³×½Ã, ½Å°³³ä ÁÖ·ù ¼Òºñ ¸ðµ¨ ±¸Ãà (2024-09-18)
Sisvel Welcomes EU SEP Regulation Rethink (2025-02-26)
¡®°­Ã¶ºÎ´ë3' »ç»ó ÃÖÃÊ »ç°Ý ¡®VAR¡¯ ½Ç½Ã (2023-10-03)
Technology Holdings to Rebrand as TH Global Capital and Expa... (2025-02-04)
Çѱ¹Áö¿ª³­¹æ°ø»ç, Áß±â ÇØ¿Ü ÁøÃâ Áö¿ø... ¹«¿ªº¸Çè°ø»ç¿Í MOU (2024-09-19)
¹Ì¼¼Ä§ ÀÌ¿ëÇÑ °¡Á¤¿ë ÇǺι̿ë±â±â ¡®Æ½Å塯 (2013-11-05)
¹ý·ü ÄÚµð³×ÀÌÆÃ ¼­ºñ½º ¡®¿¡À̺ê.¡¯ ¿ÀÇ º£Å¸ ¼­ºñ½º ½ÃÀÛ (2024-10-04)
½ÅÇÑÄ«µå, SKÅÚ·¹ÄÞ AI ±â¼ú Ȱ¿ë ÀÌ»ó°Å·¡Å½Áö½Ã½ºÅÛ °­È­ (2024-11-29)
¡®¸Ô°í º¸´Â ÇüÁ¦µé¡¯ È«Äá-¸¶Ä«¿À ޹æ Áß µ¹¹ß »óȲ? (2023-11-07)
hy, ÀÚü°³¹ß ¡®°üÀý°Ç°­¡¯ ±â´É¼º ¼ÒÀç ¡®Âü³ª¸®ÃßÃâºÐ¸»¡¯ »ó... (2024-08-13)
AEG Announces Realignment of International Business Operatio... (2025-02-08)
ŹÀçÈÆ°ú 8¸í ¹Ì³à ¼¿·´ÀÇ ¹ö¶óÀÌ¾îÆ¼ ¡®½´ÆÛ°É½º¹èƲ¡¯ (2023-11-26)
·¹µåÆäÀ̽º, ÄÜÆ®¶ó ·¹ÀÎÁö ¹Ìµå µî»êÈ­ Ãâ½Ã (2024-01-21)
ÇÇÄ¡½º ¡®Æ÷´Ï¡¯ µå¸®ÇÁÆ® Ä«·Î ¡®¿ïÆ®·¹À̽º 2024¡¯ ¿ì½Â (2024-07-07)
       [ÀÌÀü][1]....[460][461][462][463][464][465][466][467][468]...[3699][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..